SBE Prophylaxis in CIEDs Survey
|
|
|
|
|
Dear colleagues, please see the message below from Drs. AJ Batra and Mike Silka regarding a new survey reviewed and approved by the PACES Research Committee.
|
Due to the lack of prospective data and limited number of cases, there are conflicting recommendations regarding the use of SBE prophylaxis for patients with intravascular CIEDs. This brief survey is undertaken to define current practices regarding SBE prophylaxis in young patients with CIEDs, and whether practices are different for patients with and without congenital heart disease. Second, it also attempts to clarify the current use/non-use of SBE prophylaxis for non-dental procedures (endoscopy, bronchoscopy, genitourinary) in patients with intravascular CIEDs. And third, it attempts to define whether SBE prophylaxis practices differ when time since implant exceeds 6 months. As there may be variance in practice within institutions, responses are requested from each individual provider. For this survey, high risk conditions include prior infective endocarditis, surgical or transcatheter valves, any CHD repaired with prosthetic material, or any CHD repair (surgical or trans-catheter) when a residual shunt or valvar insufficiency is present. (ESC 2023 IE guidelines). Low risk conditions are generally defined as conditions other than those included as high risk.
|
We are not asking people to review specific charts. The purpose / method is to ask responders if they would treat a "theoretical" patient with various potential risk factor for endocarditis. As far as the question regarding "have you had a CIED patient develop endocarditis", again we are not asking for specifics. merely a Y/ N response. The survey should take no more than 5 minutes.
|
|
|
|
|
|
|
|
|
|
|
|
|
